3654 results for «415»
3654 results
Risk stratification of NSTEMI patients
22 May 2025 – From EuroPCR 2025
Explore the latest insights on risk stratification in NSTEMI patients through comparative analysis of established risk scores such as GRACE, HEART, and TIMI in predicting coronary artery disease severity. This session also reviews outcomes based on diabetes status and left ventricular ejection fraction, prospective validation of...
Bifurcation CAD: presentation and PCI strategies
22 May 2025 – From EuroPCR 2025
Navigate the complexities of coronary bifurcation disease with a comprehensive session covering decision-making, imaging applications, and PCI strategies. Review clinical scenarios involving left main disease, calcifications, and acute presentations. Understand the pivotal role of intracoronary imaging and explore provisional and two-stent techniques through detailed case discussions...
EuroIntervention 20th anniversary and annual editorial meeting – All EuroPCR participants welcome
22 May 2025 – From EuroPCR 2025
Mark the 20th anniversary of EuroIntervention with this special annual editorial meeting open to all EuroPCR participants. Reflect on the journal's achievements, discuss future directions, and engage with leaders in interventional cardiology to shape the evolving landscape of cardiovascular research and practice.
Refractory heart failure: combining oral therapy and device is key
21 May 2025 – From EuroPCR 2025
Address refractory heart failure management through combined oral therapy and device interventions. This session helps identify patients needing treatment escalation, reviews contemporary cardiovascular intervention indications, and emphasizes achieving optimal synergy between pharmacologic and device-based therapies through clinical case discussions.
Welcome to EuroPCR 2025
20 May 2025 – From EuroPCR 2025
Welcome to EuroPCR 2025, the premier event for interventional cardiology innovation and education, where leaders and professionals gather to shape the future of cardiovascular care.
EAPCI Fellowship Grant Awards
21 May 2025 – From EuroPCR 2025
Celebrate the achievements of emerging cardiology leaders with the EAPCI Fellowship Grant Awards session. This presentation highlights the awarded fellows' contributions and the impact of fellowship support on advancing interventional cardiology research and clinical practice.
EuroPCR 2025 Closing Ceremony
23 May 2025 – From EuroPCR 2025
Conclude your conference experience with the EuroPCR 2025 Closing Ceremony, celebrating the achievements, innovations, and advancements presented throughout the event, and setting the stage for future developments in interventional cardiology.
Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award
21 May 2025 – From EuroPCR 2025
Celebrate innovation and research excellence in interventional cardiology with the Jon DeHaan Foundation Award and Michele Pighi Young Investigator Award session. This session highlights groundbreaking work and emerging talent shaping the future of cardiovascular interventions.
Andreas Grüntzig Ethica Award
22 May 2025 – From EuroPCR 2025
Recognize excellence in interventional cardiology with the prestigious Andreas Grüntzig Ethica Award. This session honors outstanding contributions and ethical standards that advance the field and improve patient care worldwide.
Artificially synthesized optical coherence tomography images based on intravascular ultrasound-virtual histology examination of diseased coronary artery
05 May 2021
Intravascular imaging is a cornerstone of invasive management of coronary disease, requiring specialized training to interpret either IVUS or OCT. AI can facilitate interpretation by non-specialists in real time.
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry
17 Sep 2022
Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
